488 results on '"Durantel, David"'
Search Results
2. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms
3. Meeting report: 36th international conference on antiviral research in Lyon, France, March 13–17, 2023
4. SAT-389 HBV and HBsAg strongly reshape the phenotype, function and metabolism of DCs according to patients’ clinical stage
5. Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes
6. Deciphering hepatitis B virus phospho-signature in primary human hepatocytes
7. Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro
8. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
9. Publisher Correction: A first experience of transduction for differentiated HepaRG cells using lentiviral technology
10. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection
11. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis
12. Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis.
13. Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
14. Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity
15. New treatments to reach functional cure: Virological approaches
16. Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
17. A first experience of transduction for differentiated HepaRG cells using lentiviral technology
18. EGF receptor modulates HEV entry in human hepatocytes
19. Therapies against chronic hepatitis B infections: The times they are a-changin’, but the changing is slow!
20. A stable hepatitis D virus-producing cell line for host target and drug discovery
21. Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
22. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
23. Early inhibition of hepatocyte innate responses by hepatitis B virus
24. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells
25. Design, Synthesis and Evaluation of Novel 4‐(4‐Chlorobenzyl)‐6‐methylpyridazin‐3(2 H )‐one Derivatives as Hepatitis B Virus Inhibitors
26. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus
27. Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
28. Molecular elucidation of drug-induced abnormal assemblies of the Hepatitis B Virus capsid protein by solid-state NMR
29. Combined effect of Vonafexor and Interferon-alpha on HBV replication in primary human hepatocytes
30. Dual antiviral activity of farnesyl transferase inhibitor on hepatitis D virus infection revealed by RT-ddPCR
31. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals
32. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
33. Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication
34. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector
35. Novel targets for hepatitis B virus therapy
36. Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
37. Meeting report: 34th international conference on antiviral research
38. DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection
39. Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
40. Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages
41. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus
42. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes
43. A Targeted Functional RNA Interference Screen Uncovers Glypican 5 as an Entry Factor for Hepatitis B and D Viruses
44. Design, Synthesis and Evaluation of Novel 4‐(4‐Chlorobenzyl)‐6‐methylpyridazin‐3(2H)‐one Derivatives as Hepatitis B Virus Inhibitors.
45. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options
46. Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
47. HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses
48. How to get away with liver innate immunity? A viruses’ tale
49. Hypoxia‐Inducible Factor 1 Alpha–Mediated RelB/APOBEC3B Down‐regulation Allows Hepatitis B Virus Persistence
50. Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.